CCOOPER COMPANIES, INC. logo
COO//CIK 0000711404

COOPER COMPANIES, INC.

SIC 3851Ophthalmic Goodsoperating

Exchange

Nasdaq

Entity type

operating

Fiscal year end

Oct 31

Headquarters

DE

Research Summary

AI-assisted · Grounded in filings

Updated Nov 24, 2025

COOPER COMPANIES, INC.

Cooper Companies, Inc. (CIK 711404) is the global ophthalmic products specialist classified within SIC 3842 and referenced by ticker COO, designing and distributing contact lens solutions, surgical implants, and diagnostics that keep optometrists, ophthalmologists, and surgery centers well supplied. The firm’s CooperVision unit advances wearable optics across silicone hydrogel and daily disposables, while CooperSurgical pairs fertility, women’s health, and surgical consumables with precision instruments, and both rely on tight supply chains and regulatory approvals to serve a broad professional base. Its leadership must navigate FDA, EMA and other medical-device oversight, reimbursement shifts and pricing pressure in markets from North America to Asia-Pacific, which remain material risks alongside manufacturing quality-control and geopolitical trade uncertainty. The most recent public notice referenced on this profile was the Form 8-K filed December 1999, underscoring the need to track updates via filings. For the latest insight, view live SEC filings on Earnings Feed.

Market Data

Dec 4, 9:30 AM ET
$77.03+$7.95 (+11.51%)

COO · Last trade

Prev Close

$69.08

Range (29d)

$68.88 – $78.21

$65.00$70.00$75.00$80.00Nov 5Nov 14Nov 24Dec 4